Genmab — Juni 2020
-
Gentogen hvad er det for en poster hvor der var data cutoff 5/5? Den jeg så på epco var 20/1
-
This is from the ASCO poster "Data cut-off dates: safety, 24 April 2020; efficacy, 5 May 2020"
https://virtualboothdemo.s3.amazonaws.com/Genmab/Content/PDFs/Epcoritamab (GEN3013; DuoBody-CD3xCD20).pdf -
Interesting to see that patients with CR are only on 6 and 12 mg, does that indicate, when you have CR, you don’t continue to a higher dose?
-
ahh tak EL! det var den indledende absteakt hvor der stod 20/1. Ved vi hvor mange de har indrulleret på 48mg ? Det må va ca 50 de vil indrullere der
-
Ja men det er kun dose eskalering fasen de viser data fra. Ikke 2. del af studiet hvor det udelukkende er 48mg
-
og det er så ca 50 patienter de vil indrullere på 48mg (op til samlet 110 patienter)
-
-
Thanks E L, Citi were not dissatisfied with what they saw at ASCO then
-
Except for UBS and Citi all analysts are now behind the curve, there will come a large number of upgrades after the partner deal
-
Here is the link kkjoel https://www.streetinsider.
com/dr/news.php?id=16952064
Highest is UBS and Citi: 2500.Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind